Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oligonucleotide directed misfolding of RNA (ODMiR) uses short oligonucleotides to inhibit RNA function by exploiting the ability of RNA to fold into different structures with similar free energies. It is shown that the 2'-O-methyl oligonucleotide, m(CAGCCUACCCGG), can trap Escherichia coli
RNase P
RNA (M1 RNA) in a nonfunctional structure in a transcription mixture containing
RNase P
protein (C5 protein). At about 200 nM, the 12-mer thus inhibits 50% of pre-tRNA processing by
RNase P
. Roughly 10-fold more 12-mer is required to inhibit
RNase P
containing full-length, renatured
RNase P
RNA.
Diethyl pyrocarbonate
modification in the presence of 12-mer reveals increased modification of sites in and interacting with P4, suggesting a structural rearrangement of a large pseudoknot important for catalytic activity. Thus, the ODMiR method can be applied to RNAs even when folding is facilitated by a cognate protein.
...
PMID:Inhibition of Escherichia coli RNase P by oligonucleotide directed misfolding of RNA. 1462